151 related articles for article (PubMed ID: 11062062)
1. Thermodynamic mixing of molecular states of the epidermal growth factor receptor modulates macroscopic ligand binding affinity.
Holbrook MR; Slakey LL; Gross DJ
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):99-108. PubMed ID: 11062062
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor internalization rate is regulated by negative charges near the SH2 binding site Tyr992.
Holbrook MR; O'Donnell JB; Slakey LL; Gross DJ
Biochemistry; 1999 Jul; 38(29):9348-56. PubMed ID: 10413509
[TBL] [Abstract][Full Text] [Related]
3. Functional effects of glycosylation at Asn-579 of the epidermal growth factor receptor.
Whitson KB; Whitson SR; Red-Brewer ML; McCoy AJ; Vitali AA; Walker F; Johns TG; Beth AH; Staros JV
Biochemistry; 2005 Nov; 44(45):14920-31. PubMed ID: 16274239
[TBL] [Abstract][Full Text] [Related]
4. Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity.
Iyer AK; Tran KT; Borysenko CW; Cascio M; Camacho CJ; Blair HC; Bahar I; Wells A
J Cell Physiol; 2007 Jun; 211(3):748-58. PubMed ID: 17311283
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of Thr654 but not Thr669 within the juxtamembrane domain of the EGF receptor inhibits calmodulin binding.
Aifa S; Frikha F; Miled N; Johansen K; Lundström I; Svensson SP
Biochem Biophys Res Commun; 2006 Aug; 347(2):381-7. PubMed ID: 16793002
[TBL] [Abstract][Full Text] [Related]
6. Theoretical investigations of prostatic acid phosphatase.
Sharma S; Pirilä P; Kaija H; Porvari K; Vihko P; Juffer AH
Proteins; 2005 Feb; 58(2):295-308. PubMed ID: 15578709
[TBL] [Abstract][Full Text] [Related]
7. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
Li J; Ma C; Huang Y; Luo J; Huang C
Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.
Cai CQ; Peng Y; Buckley MT; Wei J; Chen F; Liebes L; Gerald WL; Pincus MR; Osman I; Lee P
Oncogene; 2008 May; 27(22):3201-10. PubMed ID: 18193092
[TBL] [Abstract][Full Text] [Related]
9. Affinity regulates spatial range of EGF receptor autocrine ligand binding.
DeWitt A; Iida T; Lam HY; Hill V; Wiley HS; Lauffenburger DA
Dev Biol; 2002 Oct; 250(2):305-16. PubMed ID: 12376105
[TBL] [Abstract][Full Text] [Related]
10. The juxtamembrane region of the epidermal growth factor receptor is required for phosphorylation of Galpha(s).
Poppleton HM; Sun H; Mullenix JB; Wiepz GJ; Bertics PJ; Patel TB
Arch Biochem Biophys; 2000 Nov; 383(2):309-17. PubMed ID: 11185568
[TBL] [Abstract][Full Text] [Related]
11. Activation mechanism of solubilized epidermal growth factor receptor tyrosine kinase.
Ge G; Wu J; Wang Y; Lin Q
Biochem Biophys Res Commun; 2002 Jan; 290(3):914-20. PubMed ID: 11798160
[TBL] [Abstract][Full Text] [Related]
12. Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation.
Talavera A; Friemann R; Gómez-Puerta S; Martinez-Fleites C; Garrido G; Rabasa A; López-Requena A; Pupo A; Johansen RF; Sánchez O; Krengel U; Moreno E
Cancer Res; 2009 Jul; 69(14):5851-9. PubMed ID: 19584289
[TBL] [Abstract][Full Text] [Related]
13. Regulation by ceramide of epidermal growth factor signal transduction and mitogenesis in cell lines overexpressing the growth factor receptor.
Gallardo G; Tabraue C; Quintana J; López-Blanco F; Cabrera J; Díaz R; Estévez F; Ruiz de Galarreta CM; Fanjul LF; Santana P
Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1305-12. PubMed ID: 11075960
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor.
Shao H; Cheng HY; Cook RG; Tweardy DJ
Cancer Res; 2003 Jul; 63(14):3923-30. PubMed ID: 12873986
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor (EGFR) signaling in cancer.
Normanno N; De Luca A; Bianco C; Strizzi L; Mancino M; Maiello MR; Carotenuto A; De Feo G; Caponigro F; Salomon DS
Gene; 2006 Jan; 366(1):2-16. PubMed ID: 16377102
[TBL] [Abstract][Full Text] [Related]
16. S-Nitrosylation of the epidermal growth factor receptor: a regulatory mechanism of receptor tyrosine kinase activity.
Murillo-Carretero M; Torroglosa A; Castro C; Villalobo A; Estrada C
Free Radic Biol Med; 2009 Feb; 46(4):471-9. PubMed ID: 19056486
[TBL] [Abstract][Full Text] [Related]
17. Identification of EGF receptor C-terminal sequences 1005-1017 and di-leucine motif 1010LL1011 as essential in EGF receptor endocytosis.
Wang Q; Zhu F; Wang Z
Exp Cell Res; 2007 Sep; 313(15):3349-63. PubMed ID: 17643422
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of mitogenic pathways through kinase-impaired mutants of the epidermal growth factor receptor.
Ewald JA; Coker KJ; Price JO; Staros JV; Guyer CA
Exp Cell Res; 2001 Aug; 268(2):262-73. PubMed ID: 11478852
[TBL] [Abstract][Full Text] [Related]
19. Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule.
Friedman M; Orlova A; Johansson E; Eriksson TL; Höidén-Guthenberg I; Tolmachev V; Nilsson FY; Ståhl S
J Mol Biol; 2008 Mar; 376(5):1388-402. PubMed ID: 18207161
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence resonance energy transfer analysis of proapoptotic CD95-EGF receptor interactions in Huh7 cells.
Eberle A; Reinehr R; Becker S; Häussinger D
Hepatology; 2005 Feb; 41(2):315-26. PubMed ID: 15660394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
